Glabridin (CAS 59870-68-7) Market Size, Share, and Outlook, 2025 Report- By Type (20% HPLC, 40% HPLC, 60% HPLC, 90% HPLC, 98% HPLC), By Application (Cosmetic, Pharmaceutical, Others), 2018-2032

Glabridin (CAS 59870-68-7) Market Outlook

Glabridin (CAS 59870-68-7) Market Size is forecast to reach $33.4 Billion in 2032 from $24.6 Billion in 2025, at an optimistic growth rate of 4.4% from 2025 to 2032. The robust Glabridin (CAS 59870-68-7) Market growth presents potential growth opportunities for companies across the industry value chain.

The comprehensive market research report presents 12-year historic and forecast data on Glabridin (CAS 59870-68-7) Market segments across 22 countries from 2021 to 2032. Key segments in the report include By Type (20% HPLC, 40% HPLC, 60% HPLC, 90% HPLC, 98% HPLC), By Application (Cosmetic, Pharmaceutical, Others). Over 70 tables and charts showcase findings from our latest survey report on Glabridin (CAS 59870-68-7) Markets.

Glabridin (CAS 59870-68-7) Market Insights, 2025: Glabridin: Key Drivers and Opportunities

The global glabridin market is experiencing strong growth due to increasing demand in the cosmetics, pharmaceutical, and nutraceutical industries. A primary driver is the rising consumer preference for natural and plant-based skincare ingredients. Derived from licorice root, glabridin is widely recognized for its skin-lightening, anti-inflammatory, and antioxidant properties, making it a popular ingredient in anti-aging and hyperpigmentation treatment products. The rapid expansion of the global beauty and personal care market, particularly in Asia-Pacific regions such as China, Japan, and South Korea, is fueling demand for glabridin-based formulations. Regulatory approvals for natural cosmetics and stringent restrictions on synthetic whitening agents like hydroquinone are also boosting its adoption.

Significant opportunities exist in the pharmaceutical and nutraceutical sectors, where glabridin is gaining recognition for its potential anti-diabetic, neuroprotective, and cardiovascular health benefits. Research into its role in preventing oxidative stress-related diseases is opening new commercial avenues for functional food and supplement manufacturers. Companies like Sabinsa Corporation and Aktin Chemicals are expanding their production capacities to meet growing global demand. Moreover, the development of nano-encapsulation technologies is enhancing glabridin’s bioavailability, allowing for more effective topical and oral applications.

Five Trends that will define global Glabridin (CAS 59870-68-7) Market in 2025 and Beyond

A closer look at the multi-million global market for Glabridin (CAS 59870-68-7) Market identifies rapidly shifting consumer preferences across categories. By focusing on growth and resilience, leading Glabridin (CAS 59870-68-7) Companies are prioritizing their investments across categories, markets, and geographies. The report analyses the most important market trends shaping the new landscape to support better decisions for the long and short-term future.

What are the biggest opportunities for growth in the Glabridin (CAS 59870-68-7) Industry?

The Glabridin (CAS 59870-68-7) Market sector demonstrated remarkable resilience over the past year across developed and developing economies. Further, the market presents significant opportunities to leverage the existing momentum towards actions by 2032. On the other hand, recent macroeconomic developments including rising inflation and supply chain disruptions are putting pressure on companies. The chapter assists users to identify growth avenues and address business challenges to make informed commercial decisions with unique insights, data forecasts, and in-depth market analyses.

Glabridin (CAS 59870-68-7) Market Segment Insights

The Glabridin (CAS 59870-68-7) Industry presents strong offers across categories. The analytical report offers forecasts of Glabridin (CAS 59870-68-7) Industry performance across segments and countries. Key segments in the industry include- By Type (20% HPLC, 40% HPLC, 60% HPLC, 90% HPLC, 98% HPLC), By Application (Cosmetic, Pharmaceutical, Others). The largest types, applications, and sales channels, fastest growing segments, and the key factors driving each of the categories are included in the report.

Forecasts of each segment across five regions are provided from 2021 through 2032 for Asia Pacific, North America, Europe, South America, Middle East, and African regions. In addition, Glabridin (CAS 59870-68-7) Market size outlook is provided for 22 countries across these regions.

Glabridin (CAS 59870-68-7) Industry Value Chain

The chapter identifies potential companies and their operations across the global Glabridin (CAS 59870-68-7) Industry ecosystem. It assists decision-makers in evaluating global Glabridin (CAS 59870-68-7) Market fundamentals, market dynamics, and disruptive trends across the value chain segments.

Scenario Analysis and Forecasts

Strategic decision-making in the Glabridin (CAS 59870-68-7) Industry is multi-faceted with the increased need for planning across scenarios. The report provides forecasts across three case scenarios- low growth, reference case, and high growth cases.

Asia Pacific Glabridin (CAS 59870-68-7) Market Analysis- A Promising Growth Arena for Business Expansion

As companies increasingly expand across promising Asia Pacific markets with a combined population of over 4.5 billion, the medium-to-long-term future remains robust. The presence of the fastest-growing economies such as China, India, Thailand, Indonesia, and Vietnam coupled with strengthening middle-class populations and rising disposable incomes drive the market. In particular, China and India are witnessing rapid shifts in consumer purchasing behavior. China is recovering steadily with optimistic forecasts for 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.

The State of Europe Glabridin (CAS 59870-68-7) Industry 2025- Focus on Accelerating Competitiveness

As companies opt for an integrated agenda for competitiveness, the year 2025 presents optimistic scenarios for companies across the ecosystem. With signs of economic recovery across markets, companies are increasing their investments. Europe is one of the largest markets for Glabridin (CAS 59870-68-7) Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. Increasing omnichannel shopping amidst robust consumer demand for value purchases shapes the market outlook. The report analyses the key Glabridin (CAS 59870-68-7) Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.

The US Glabridin (CAS 59870-68-7) Market Insights- Executives are most excited about opportunities for the US Glabridin (CAS 59870-68-7) Industry.

Easing inflation coupled with strengthening consumer sentiment is encouraging aggressive actions from the US Glabridin (CAS 59870-68-7) Companies. Market players consistently focusing on innovation and pursuing new ways to create value are set to excel in 2025. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Glabridin (CAS 59870-68-7) Market.

Latin American Glabridin (CAS 59870-68-7) Market outlook rebounds in line with economic growth.

Underlying demand remains higher among urban consumers with an optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries. Increased consumer spending has been reported since H2-2024 and the prospects remain strong for 2025. Aggressive ecosystem moves to create new sources of income are widely observed across markets in the region. Marketing activities focused on customer insights, operations, and support functions are quickly gaining business growth in the region.

Middle East and Africa Glabridin (CAS 59870-68-7) Markets- New Opportunities for Companies Harnessing Diversity

Rapid growth in burgeoning urban locations coupled with a young and fast-growing population base is attracting new investments in the Middle East and African Glabridin (CAS 59870-68-7) Markets. Designing expansion and marketing strategies to cater to the local consumer base supports the market prospects. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies. On the other hand, Middle Eastern Glabridin (CAS 59870-68-7) Markets including the UAE, Saudi Arabia, Qatar, and Oman continue to offer lucrative pockets of growth.

Competitive Landscape- How Glabridin (CAS 59870-68-7) Companies outcompete in 2025 and Beyond?

The ability to respond quickly to evolving consumer preferences and adapt businesses to niche consumer segments remains a key growth factor. The report identifies the leading companies in the industry and provides their revenue for 2024. The market shares of each company are also included in the report. Further, business profiles, SWOT analysis, and financial analysis of each company are provided in detail. Key companies analyzed in the report include Arkure Health Care, Azelis SA, Cayman Chemical, Foodchem International Corp, Glentham Life Sciences Ltd, Haihang Industry Co. Ltd, Herbal Creations, Herbo Nutra, Kan Phytochemicals Pvt. Ltd, Kavya Pharma, M.C.Biotec Inc, Merck KGaA, Plamed Green Science Group, Sabinsa Corp, Starchem Enterprises Ltd, Suzhou Springchem International Co. Ltd, Tianjin YR Chemspec Technology Co. Ltd, Xi'an Kintai Biotech Inc, Xi'an Sost Biotech Co.,Ltd.

Glabridin (CAS 59870-68-7) Market Scope and Segmentation

By Type

20% HPLC

40% HPLC

60% HPLC

90% HPLC

98% HPLC

By Application

Cosmetic

Pharmaceutical

Others

Countries Included-

North America- US, Canada, Mexico

Europe- Germany, France, UK, Spain, Italy, Benelux, Turkey, Russia, Rest of Europe

Asia Pacific- China, India, Japan, South Korea, South East Asia, Australia, Rest of APAC

South and Central America- Brazil, Argentina, Chile, Rest of SCA

Middle East and Africa- Saudi Arabia, the UAE, Israel, South Africa, Algeria, Nigeria, Rest of Middle East, Rest of Africa

Companies Included in the Glabridin (CAS 59870-68-7) Market Research-

Arkure Health Care

Azelis SA

Cayman Chemical

Foodchem International Corp

Glentham Life Sciences Ltd

Haihang Industry Co. Ltd

Herbal Creations

Herbo Nutra

Kan Phytochemicals Pvt. Ltd

Kavya Pharma

M.C.Biotec Inc

Merck KGaA

Plamed Green Science Group

Sabinsa Corp

Starchem Enterprises Ltd

Suzhou Springchem International Co. Ltd

Tianjin YR Chemspec Technology Co. Ltd

Xi'an Kintai Biotech Inc

Xi'an Sost Biotech Co.,Ltd

Reasons to Buy the report

• Make informed decisions through long and short-term forecasts across 22 countries and segments.
• Evaluate market fundamentals, dynamics, and disrupting trends set to shape 2025 and beyond.
• Gain a clear understanding of the competitive landscape, with product portfolio and growth strategies.
• Get an integrated understanding of the entire market ecosystem and companies.
• Stay ahead of the competition through plans for growth in a changing environment for your geographic expansion.
• Assess the impact of advanced technologies and identify growth opportunities based on actionable data and insights.
• Get free Excel spreadsheet and PPT versions along with the report PDF.